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ABSTRACTS 
RIBOFLAVIN IN EQUINE DIET. Lit-
tle work has been done on the nutri-
tional requirements of the horse. The 
fact that the B vitamins are produced by 
the symbiotic action of microorganisms in 
the ruminant stomach is well established, 
but virtually nothing is known about 
dietary requirements for these factors in 
the horse. The occurrence of one or more 
physiological responses in a horse re-
stricted to a riboflavin deficient diet af-
fords confirmatory evidence of the dietary 
essentiality of this vitamin for equidae. 
It is well recognized that a deficiency of 
riboflavin in the diet is reflected in dimin-
ished urinary excretion of riboflavin. 
In investigations on horses, data have 
been secured on the influence of the ribo-
flavin content of the diet, on the amount 
excreted in urine, the amount in the 
blood, and the influence on the growth 
and general well-being of the animals. Ra-
tions contained dried beet pulp, ground 
corn, purified casein, brewer's yeast, and 
dicalcium phosphate to which was added 
synthetic riboflavin in mg. per 100 Gm. of 
ration. The total riboflavin content of 
ration in mg. per 100 Gm. in the 4 differ-
ent rations were: IV ration 0.08, V ration 
0.33, VI ration 0.36, and VI-B ration 1.18. 
Urine was collected quantitatively into a 
black bottle by means of a specially de-
signed cage to exclude contamination by 
feces. The riboflavin was measured by an 
improved microbiological method. 
Horses fed on ration IV did not consume 
as much feed as those that received added 
amounts of riboflavin and other B vita-
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mins. A change in the amount of ribo-
flavin ingested is reflected in the amount 
secreted in the urine within a period of 
a few weeks. One month after the horses 
were placed on the ration containing 80 
mg. of riboflavin per 100 Gm., the daily 
urinary excretion was too low to measure 
in one animal, and in the other two it was 
less than 1/14 of the level of the animals 
when fed on stock ration. By the second 
month urinary excretion of riboflavin was 
insufficient to measure. 
Urinary excretion of riboflavin of horses 
on ration IV was only a fraction of the 
intake. This is different from nicotinic 
acid in that the urinary excretion may 
exceed the intake. As previously men-
tioned, the urinary excretion of riboflavin 
by animals for which it is a dietary essen-
tial is closely correlated with the intake 
and clinically low urinary values are 
characteristic of ariboflavinosis. On the 
basis of this criterion, the evidence strong-
ly indicated that riboflavin is a dietary es-
sential for the horse just as for other 
simple stomach animals that have been 
studied. The fact that a source of some 
of the B vitamins including riboflavin is 
necessary in the ration for satisfactory 
growth performance of horses is further 
confirmatory evidence of its dietary essen-
tiality for equidae. 
The riboflavin requirements for horses 
are somewhat less than for dogs and prob-
ably of about the same order as for hu-
mans. It is shown that 44 gamma g. per 
kg. of body weight per day is adequate. 
Each time urine was collected blood 
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was drawn and assayed for riboflavin. The 
riboflavin content of blood failed to show 
a consistent relationship to the intake. 
(Pearson, P. B., Sheybani, M. K., and 
Schmidt, H. 1944. Riboflavin in the nutri-
tion of the horse. Arch. Biochem. 
3(3):467-474.) 
A CTION OF SULFONAMIDES IN-
HIBITED BY PROCAINE. It has 
been demonstrated that p-amino benzoic 
acid and related compounds, including 
procaine, exert a marked inhibiting effect 
on the bacteriostatic action of sulfanila-
mide on hemolytic streptococci in vitro. 
It has been found that sulfapyridine re-
quired 5 times as much p-amino benzoic 
acid as needed for sulfanilamide to pro-
duce the same degree of inhibition. It 
has been shown that procaine exerts an 
inhibiting effect on the bacteriostatic ac-
tion of sulfathiazole in wounds infected 
with Staphylococcus a'w'eus. During the 
course of spinal anesthesia there is no ap-
preciable concentration of procaine in the 
blood stream. Once it gets in the blood 
stream the procaine is rapidly hydrolyzed 
by an enzyme and some of the free amino 
groups resulting from this hydrolysis are 
further acetylated by a less active enzyme 
and the products are rapidly excreted in 
the urine. An average of 90 percent of 
injected procaine is thus excreted in the 
urine in the form of products of detoxifi-
cation. 
There was found to be an inhibiting ac-
tion by procaine in concentrations of 1 mg. 
per 100 cc. or higher on the bacteriostati~ 
action of sulfadiazine concentrations as 
high as 20 mg. per 100 cc. Tests were made 
in vitro with type III pneumococci in hu-
man blood. 
Procaine in concentration of 1 mg. per 
100 cc. or higher permitted the free multi-
plication of type III pneumococci in 
presence of concentrations of sulfathiazole 
as high as 40 mg. per 100 cc. Experiments 
showed that if blood was taken before each 
procedure and again at intervals after the 
injection of procaine the greatest amount 
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of inhibition was found % to 2 hours after 
injection of the procaine was completed. 
Experiments carried out with sulfathia-
zole in concentrations ranging from 2 to 4 
mg. per 100 cc. and procaine totaling up 
to 1 Gm., showed only a slight inhibiting 
effect. 
Experiments with procaine in vivo in 
human serum showed an inhibiting effect 
of the bacteriostatic action of sulfathia-
zole in concentrations as high as 25 mg. 
per 100 cc. The procaine concentration 
was found to be 1.7 mg. per 100 cc. The 
possibility of procaine being absorbed 
from an area of local infiltration with re-
spect to inhibiting the bacteriostatic ac-
tion of systemic sulfanilamide is clinically 
insignificant except in rare cases. 
It is suggested that local anesthetic drugs 
other than p-amino benzoic acid deriva-
tives be used for infiltrations when per-
forming punctures into infected areas. 
(Peterson, O. L., and Finland, M. 1944, 
The inhibition by procaine on the bac-
teriostatic action of the sulfonamides. 
Am. J. Med. Sci. 207(2):166-175') 
EFFECTS OF DEL VINAL SODIUM IN CANINE ANESTHESIA. Ex-
perimentation was conducted to obtain 
further information on the effects of 
Delvinal Sodium, 5 ethyl (I-methyl 1 
butenyl) barbituric acid, especially when 
used as a surgical anesthesia in dogs. The 
surgical anesthetic dose was determined 
and its effects upon the period of anes-
thesia, recovery, temperature, pulse, and 
respiration were observed and compared 
with those produced by the sodium salts 
of pentothal, pentobarbital, and amy tal. 
Also studied were the effects of single and 
repeated doses of this drug upon these 
variables and upon blood cells, blood glu-
cose, blood and urine, urea and uric acid, 
and the specific gravity of urine. 
Male and female dogs weighing from 
3.5 to 32.0 kg. were used in the experi-
ment. Prior to the studies the dogs were 
hospitalized and kept under observation 
for at least 2 weeks. Food and water were 
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withheld from the dogs for 18 hours be-
fore drug administration. Each dog was 
rested for at least 3 weeks following each 
injection of a barbiturate except when 
drug tolerance was tested. 
To determine the approximate surgical 
anesthetic and lethal doses a solution of 
Delvinal Sodium (64.8 mg. per cc.) was 
injected intravenously until the various 
reflexes were abolished. In these prelimi-
nary experiments the injections extended 
over a period of not more than 20 minutes. 
In subsequent experiments the solutions 
were injected intravenously in less than 
1 minute. Observations are listed as fol-
lows: 
1. Intravenous injections of 48.8 mg. of 
Delvinal Sodium per kg. of body weight 
produced surgical anesthesia in most dogs, 
while 25 mg. per kg. produced relaxation 
and sleep. There was no evidence of toxic 
or aftereffects from the drug. 
2. Delvinal Sodium produced a longer 
period of surgical anesthesia in dogs than 
either amy tal or pentobarbital. This new 
barbiturate produced no annoying reac-
tions or violent movements during induc-
tion and recovery periods and therefore 
could be administered without prelimi-
nary treatment with morphine and atro-
pine. 
3. Similar to the action of the other 
barbiturates, Delvinal Sodium caused de-
pression of temperature, pulse rate, and 
respiratory rate during anesthesia. These 
rose during the recovery phase and were 
completely normal at the time of full re-
covery. 
4. Dogs receiving weekly surgical anes-
thetic doses developed no tolerance to this 
barbiturate. 
5. Although a reduction occurred in the 
hemoglobin content and in the number 
of erythrocytes and leucocytes during 
periods of anesthesia there was a com-
plete return to normal when the animals 
recovered from the drug. 
6. Glucose concentrations fluctuated 
considerably following injections of large 
doses of the barbiturate. However, aver-
ages showed an increase during surgical 
anesthesia followed by a decrease below 
initial value during deep sleep. 
7. Weekly doses of Delvinal Sodium had 
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no effect on the concentration of blood-
urea nitrogen and uric acid and their ex-
cretion remained normal. The specific 
gravity of the urine increased slightly 
during anesthesia but always returned to 
normal upon recovery from the anesthesia. 
(Allison, J. B., Seeley, R. D., and Morris, 
M. L. 1944. A study of some effects of 
surgical anesthetic doses of Delvinal So-
dium in the dog. Am. J. Vet. Res. 
5(14) :62-69.) 
"WRYTAIL" IN CATTLE. "Wry tail" 
is a malformation consisting of a 
distortion of the tail head, the base of the 
tail being set at an angle to the vertebral 
column instead of in line with it. This 
abnormality is discriminated against by 
purebred dairy cattle breeders. Informa-
tion on the prevalence of "wry tail" among 
Jersey cattle was recently collected from 
10 herds in Kansas, Missouri, Texas, and 
Colorado. One-hundred-seventeen ani-
mals were found to have "wry tail." An 
analysis was made of the mode of inheri-
tance in 3 of the herds which had a total 
of 73 affected animals. 
The fact that "wry tailed" offspring were 
produced when both parents appeared 
normal fits the assumption that the char-
acter is inherited as a recessive. An esti-
mate was made of the gene frequency, 
based on the data accumulated in the 10 
herds. The estimated frequency of the 
"wry tail" gene was 57.8 percent. 
The fact that 117 or 34 percent of the 
350 animals observed in the 10 herds were 
homozygous for the "wry tail" character, 
162 or 46 percent were probably hetero-
zygous, and 71 or only 20 percent were 
non-carriers indicates the degree to which 
the gene is disseminated through these 
herds. There is no evidence to indicate 
that the direction of tail set is controlled 
by any genetic factor. 
The occurrence of "wry tail" in other 
breeds of dairy cattle was investigated. It 
was found in a 34 herd survey of Brown 
Swiss cattle that the incidence of the gene 
for "wry tail" was almost as high as the 
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Jersey herds studied. The gene frequency 
for "wry tail" was 44.7 percent. There is 
no extensive survey for the "wry tail" 
character in Guernseys, Holsteins, and 
Ayrshires. It has been definitely observed 
in each of these breeds of dairy cattle. 
(Atkeson, F. W., Eldredge, F., and Ibsen, 
H. 1. 1944. Prevalence of "wry tail" in 
cattle. J. Heredity. 35(1):11-14.) 
T EST FOR RECOGNITION OF HY-PERSENSITIVITY TO SULFONA-
MIDES. Experimentation was conducted 
on an intradermal test using human serum 
from patients recelvmg sulfonamides 
orally. Investigation included the study 
of 76 patients at Johns Hopkins Hospital, 
of which 46 were thought to be clinically 
hypersensitive to various sulfonamide 
drugs. The 30 supposedly not hypersensi-
tive served as controls. The various sera 
were obtained from patients suffering 
from acute bacterial infection who had 
been treated with one or other of the 
drugs. More than 300 intradermal tests 
were performed on the patients using 40 
different samples of serum as testing 
agents, and each of the sera used contained 
one of the common sulfonamide com-
pounds, namely: sulfanilamide, sulfathia-
zole, sulfadiazine, and sulfamerazine at 
a drug level of 2 to 25 mg. percent. 
The intradermal test required the in-
jection of 0.05 cc. of control serum and 
0.05 cc. of each of the sulfonamide sera 
intra cutaneously in the forearm. The size 
of the wheal and the diameter of the 
erythema produced were measured im-
mediately after injection and at intervals 
of 5 minutes for 20 minutes. The initial 
wheal was found to be 6 or 7 mm. in 
diameter and in negative tests or in con-
trols it increased only 1 or 2 mm. in size. 
Positive tests in hypersensitive patients 
showed an immediate increase in size of 
the homologous wheal up to 12 to 18 mm. 
in diameter, with intense erythema 30 to 
40 mm. in diameter. The reaction reached 
its height 15 minutes after injection and 
completely disappeared by the end of an 
hour and a half. A difference between the 
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size of the control wheal and the size of 
the test wheal of at least 4 mm. in diame-
ter was used as a criterion for positivity. 
A summary of the experimental data 
showed that of 30 definitely hypersensi-
tive patients, 18 were sensitive to sulfa-
thiazole alone, 3 to sulfanilamide alone, 2 
to sulfadiazine alone, and 4 to sulfamera-
zine. Three other patients were each sensi-
tive to 2 different drugs. These results 
showed sulfathiazole to be the most dan-
gerous in producing hypersensitive states. 
Of 64 patients who had received one of 
the sul£onamides therapeutically and were 
tested with homologous sulfonamide 
serum, 30 were definitely hypersensitive. 
Twenty-eight of these individuals gave 
positive skin tests thus establishing the 
reliability of the test at more than 90 per-
cent. 
Intradermal tests were performed on 
50 patients with a different sulfonamide 
than that which they received therapeu-
tically. Of these only 3 of the 25 defi-
nitely hypersensitive individuals gave 
positive skin tests indicating that the test 
is relatively specific for the individual 
sulfonamide drugs. Of 11 persons having 
never received a sulfonamide drug in any 
form only one gave a positive test and that 
person had a family history of allergy in 
some form. 
Several individuals gave positive skin 
tests many months after the occurrence 
of clinical hypersensitivity and 3 cases 
were found to be skin positive for the 
homologous sulfonamide from 1 to 5 years 
after the drug reaction. This suggests that 
the hypersensitivity to sulfonamides may 
persist for that length of time. 
The consistency of positive skin tests in 
sensitive individuals adds evidence to the 
fact that drug sensitivity is an allergic re-
action. It was suggested that the sensitiz-
ing antigen may be a sulfonamide-plasma-
protein combination which occurs in vivo 
in the blood of patients during sulfona-
mide therapy, the sulfonamide probably 
acting as a haptene. 
(Leftwich, W. B. An intradermal test for 
the recognition of hypersensitivity to the 
sulfonamide drugs. Bul. Johns Hopkins 
Hasp. 74(1):26-48.) 
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